Randomized comparative study between extensile lateral and sinus tarsi approaches for the treatment of Sanders type 2 calcaneal fracture

医学 跟骨骨折 可视模拟标度 随机对照试验 脚踝 跟骨 距下关节 运动范围 外科 还原(数学) 几何学 数学
作者
Chul Hyun Park,Hongfei Yan,Jeongjin Park
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:103-B (2): 286-293 被引量:28
标识
DOI:10.1302/0301-620x.103b.bjj-2020-1313.r1
摘要

AIMS: No randomized comparative study has compared the extensile lateral approach (ELA) and sinus tarsi approach (STA) for Sanders type 2 calcaneal fractures. This randomized comparative study was conducted to confirm whether the STA was prone to fewer wound complications than the ELA. METHODS: Between August 2013 and August 2018, 64 patients with Sanders type 2 calcaneus fractures were randomly assigned to receive surgical treatment by the ELA (32 patients) and STA (32 patients). The primary outcome was development of wound complications. The secondary outcomes were postoperative complications, pain scored of a visual analogue scale (VAS), American Orthopaedic Foot and Ankle Society (AOFAS) score, 36-item Short Form health survey, operative duration, subtalar joint range of motion (ROM), Böhler's angle and calcaneal width, and posterior facet reduction. RESULTS: Although four patients (12.5%) in the ELA groups and none in the STA group experienced complications, the difference was not statistically significant (p = 0.113). VAS and AOFAS score were significantly better in the STA group than in the ELA group at six months (p = 0.017 and p = 0.021), but not at 12 months (p = 0.096 and p = 0.200) after surgery. The operation time was significantly shorter in the STA group than in the ELA group (p < 0.001). The subtalar joint ROM was significantly better in the STA group (p = 0.015). Assessment of the amount of postoperative reduction compared with the uninjured limb showed significant restoration of calcaneal width in the ELA group compared with that in the STA group (p < 0.001). CONCLUSION: 2021;103-B(2):286-293.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青应助啦啦啦采纳,获得10
3秒前
4秒前
4秒前
6秒前
我是老大应助傻子与白痴采纳,获得10
9秒前
pluto应助默岱采纳,获得10
10秒前
大模型应助Ade采纳,获得10
10秒前
乐乐应助小刺采纳,获得10
10秒前
10秒前
汉堡包应助诸葛特曼采纳,获得10
11秒前
天天快乐应助科研通管家采纳,获得10
12秒前
吴DrYDYY发布了新的文献求助10
12秒前
赘婿应助科研通管家采纳,获得10
12秒前
12秒前
海山应助科研通管家采纳,获得10
12秒前
小蘑菇应助科研通管家采纳,获得10
13秒前
华仔应助科研通管家采纳,获得10
13秒前
海山应助科研通管家采纳,获得10
13秒前
Mia发布了新的文献求助10
13秒前
传奇3应助科研通管家采纳,获得10
13秒前
14秒前
14秒前
乐乐应助科研通管家采纳,获得10
14秒前
14秒前
14秒前
14秒前
15秒前
15秒前
上官若男应助科研通管家采纳,获得10
15秒前
monica01010发布了新的文献求助10
15秒前
16秒前
遆思畅完成签到,获得积分10
16秒前
16秒前
齐天大圣完成签到 ,获得积分10
17秒前
阿呷惹发布了新的文献求助10
17秒前
18秒前
18秒前
bkagyin应助shinan采纳,获得10
19秒前
研友_VZG7GZ应助合适的翠柏采纳,获得10
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6963875
求助须知:如何正确求助?哪些是违规求助? 8645852
关于积分的说明 18336814
捐赠科研通 6414587
什么是DOI,文献DOI怎么找? 3086947
关于科研通互助平台的介绍 2136466
邀请新用户注册赠送积分活动 2063413